// App-Quantinova.ai

e15118 : Novel anti-PD-1 antibodies not acting through PD-1/pdl-1 blockade that enhance tumor clearance.

Researchers

Presenter

  • Craig Fenwick

Principal Investigators

  • Juan-Luis Loredo-Varela

  • Victor Joo

  • Celine Pellaton

  • Alex Farina

  • Navina Rajah

  • Thibaut Decaillon

  • Line Esteves-Leuenberger

  • Madeleine Suffiotti

  • Khalid Ohmiti

  • Raphael Gottardo

  • Winfried Weissenhorn

  • Giuseppe Pantaleo

Medical Centers

  • MabQuest SA, Pully, Switzerland

  • Univ. Grenoble Alpes, Grenoble, France

  • CHUV, Lausanne, Switzerland

  • CHUV, Epalinges, Switzerland

  • CHUV, Lausanne, Switzerland

  • Fred Hutchinson Institute, Seattle, WA

  • Univ. Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France

  • MabQuest SA, Pully, Switzerland

Locations

  • France

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 8A

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved